Dapagliflozin in High-Risk Type 2 Diabetes Reduces Hospitalization for Heart Failure ...
Aug 1, 2019 - The only cardiovascular benefit to treatment with dapagliflozin was a reduction in the likelihood of hospitalization; 125 patients would need to be treated for 10 years to prevent one hospitalization.
American Family Physician : POEMs
https://www.aafp.org/afp/2019/0801/p184.html
navigate_before 1 navigate_next